When the Schumer-Rounds Amendment was introduced in the Senate, it explicitly defined “Non-Human Intelligence” in legal text ...
Can you 'live long and prosper' by learning economics from Star Trek? Or is that 'highly illogical?'
It might seem worlds away from the Earth we know. But can "Star Trek" teach us anything about the economics of our own ...
For a certain type of science-fiction fan, Exodus was the biggest announcement out of the 2025 Game Awards. Those fans just ...
All the players who rocked our world, in the year of Oasis reunions, Black Sabbath farewells, and guitarists keeping their ...
Now, the new film Predator: Badlands is getting attention for its prominent use of Weyland-Yutani, the organization that has been a major part of the Alien franchise ...
Is it the invasion of the genome snatchers? Just in case the idea of aliens walking around in human skin suits wasn’t frightening enough. An outlandish study asserts that aliens might have abducted us ...
This is something we have rarely seen in the streaming wars era: a current original series from one major streamer getting a release on another major streamer. That’s what happened Sunday, Sept. 28, ...
Alien: Earth definitely gets a lot right, but after watching the season 1 finale, I'm torn, because it gets a lot of things wrong, too. There's clear commitment to certain aspects of the Alien ...
Zenas BioPharma has secured up to $300 million from Royalty Pharma in return for royalties on sales of lead autoimmune candidate obexelimab. The cash is intended to help Zenas get its star asset ...
Aug 25 (Reuters) - Royalty Pharma (RPRX.O), opens new tab has agreed to buy a royalty interest in Amgen's (AMGN.O), opens new tab drug for small cell lung cancer from BeOne Medicines (688235.SS), ...
The Alien franchise has always focused on just one titular alien — the Xenomorph. Yes, over the years, we got extrapolations of the Xenomorph, like the Queen, and the facehuggers. Yet they all still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results